CClinicalTrials.gg
CompletedNCT06702358Updated Nov 22, 2024

Potential Therapeutic Implications of Laser Acupoints on Visceral Fat and Hormonal Changes in Post-menopausal Women

An interventional study of Potential Therapeutic Implications of laser Acupoints on Visceral Fat and Hormonal Changes in Post-menopausal Women in Post-menopausal Women and Visceral Fat, sponsored by Kafrelsheikh University. Completed at 1 site in Egypt. Open to female participants aged 50 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-11-22.

Sponsored by Kafrelsheikh University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Jul 2024, registered Nov 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
50 Years to 65 Years
Sex
Female
01

Study summary

Potential Therapeutic Implications of laser Acupoints on Visceral Fat and Hormonal Changes in Post-menopausal Women

Read the detailed description

All the patients fitted the inclusion criteria, will be given explanation of the treatment protocol in their understandable language.

Treatment procedures. Group (A): will receive laser acupuncture in addition to traditional treatment (low calorie-diet and physical activity) Group (B): will receive traditional treatment only

Laser acupuncture technique:

Application of laser acupuncture on 10 acupuncture procedure for each woman which will be detected by therapist according to Acupuncture points Will stimulate St 25 (Tianshu), St 36 (Zusanli), Liv 3 (Taichong); P 6 (Neiguan), H 7 (Shenmen) for the psychical aspect of the therapy and Auriculothera- py: 55 (Shenmen) and 87 (Stomach) Each point stimulating will be Stimulation time, 30 s/point two sessions per week for 8 weeks.

02

Conditions studied

  • Post-menopausal Women
  • Visceral Fat
03

In context

Lead sponsor

Kafrelsheikh University is the lead sponsor of 285 studies on the registry; 110 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Post-menopausal women
  • Woman with visceral obesity
  • with age ranges from 50-65years
  • Body mass index (BMI) more than 30 kg/m2
  • WHR more than 0.8

Exclusion criteria

Exclusion Criteria:

  • Endometrial cancer

    • Insulin resistance
    • Or metabolic disorders
  • Diabetes
  • Hypertensive •NOT receiving any medication of obesity
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Other
    Infrared laser diode

    Laser pointer instruments Product Details Infrared laser diode made in Italy, it must be perpendicular with direct contact to each point. Each point will stimulate bilaterally by a laser beam of the following parameters wave length 904 nm; strength, 24 mW; energy, 0.1 J; stimulation time, 30 s/point

    Other: Potential Therapeutic Implications of laser Acupoints on Visceral Fat and Hormonal Changes in Post-menopausal Women

Interventions

  • OtherPotential Therapeutic Implications of laser Acupoints on Visceral Fat and Hormonal Changes in Post-menopausal Women

    Application of laser acupuncture ( E M E ) on 10 acupuncture procedure for each woman which will be detected by therapist according to Acupuncture points Will stimulate St 25 (Tianshu), St 36 (Zusanli), Liv 3 (Taichong); P 6 (Neiguan), H 7 (Shenmen) for the psychical aspect of the therapy and Auriculothera- py: 55 (Shenmen) and 87 (Stomach) Each point stimulating will be Stimulation time, 30 s/point

06

What researchers measure

Primary outcomes

  1. Potential Therapeutic Implications of laser Acupoints on Visceral Fat and Hormonal Changes in Post-menopausal Women

    measured in both group before and after treatment. To get in touch with the hunger and satiety cues,BMI ,WHR and serum insulin level.

    Time frame: for 8 weeks

  2. Body Mass Index (BMI)

    The weight in kg

    Time frame: for 8 weeks

07

Study locations

1 site
  • Nawal Reda Rashad Mohamed
    Cairo, US, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 22, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06702358
Lead sponsor
Kafrelsheikh University
Responsible party
Nawal Reda Rashad Mohamed (DEPARTEMENT OF PHYSICAL THYRAPY FOR WOMAN'S HEALTH, Kafrelsheikh University) — Principal investigator
First posted
Nov 22, 2024
Start date
Jul 1, 2024
Primary completion
Sep 1, 2024
Completion
Oct 1, 2024
Last update
Nov 22, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion